Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Extended regimens of the contraceptive vaginal ring: a randomized trial.

Miller L, Verhoeven CH, Hout Ji.

Obstet Gynecol. 2005 Sep;106(3):473-82.

PMID:
16135576
2.

Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.

Oddsson K, Leifels-Fischer B, de Melo NR, Wiel-Masson D, Benedetto C, Verhoeven CH, Dieben TO.

Contraception. 2005 Mar;71(3):176-82.

PMID:
15722066
3.

Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.

Oddsson K, Leifels-Fischer B, Wiel-Masson D, de Melo NR, Benedetto C, Verhoeven CH, Dieben TO.

Hum Reprod. 2005 Feb;20(2):557-62. Epub 2004 Nov 11.

PMID:
15539438
4.

Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.

Duijkers IJ, Klipping C, Verhoeven CH, Dieben TO.

Hum Reprod. 2004 Nov;19(11):2668-73. Epub 2004 Aug 27.

PMID:
15333593
5.

Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.

Duijkers IJ, Verhoeven CH, Dieben TO, Klipping C.

Hum Reprod. 2004 Nov;19(11):2674-9. Epub 2004 Aug 19.

PMID:
15319379
6.

The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.

Verhoeven CH, Dieben TO.

Contraception. 2004 Mar;69(3):197-9.

PMID:
14969666
7.

The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.

Verhoeven CH, van den Heuvel MW, Mulders TM, Dieben TO.

Contraception. 2004 Feb;69(2):129-32.

PMID:
14759617
8.

The in vivo metabolism of tibolone in animal species.

Verhoeven CH, Vos RM, Delbressine LP.

Eur J Drug Metab Pharmacokinet. 2002 Jan-Mar;27(1):1-10.

PMID:
11996321
9.

Identification of the human P450 enzymes involved in the in vitro metabolism of the synthetic steroidal hormones Org 4060 and Org 30659.

Verhoeven CH, van Munster TT, Groothuis GM, Vos RM, Rietjens IM.

Xenobiotica. 2002 Feb;32(2):109-18.

PMID:
11871398
10.

The in vivo human metabolism of tibolone.

Vos RM, Krebbers SF, Verhoeven CH, Delbressine LP.

Drug Metab Dispos. 2002 Feb;30(2):106-12.

PMID:
11792677
11.

Excretion and metabolism of desogestrel in healthy postmenopausal women.

Verhoeven CH, Gloudemans RH, Peeters PA, van Lier JJ, Verheggen FT, Groothuis GM, Rietjens IM, Vos RM.

J Steroid Biochem Mol Biol. 2001 Nov;78(5):471-80.

PMID:
11738557
12.

Metabolism of norethisterone and norethisterone derivatives in rat uterus, vagina, and aorta.

Blom MJ, Wassink MG, van Wijk F, Ederveen AG, Kloosterboer HJ, Verhoeven CH, Lambert JG, Goos HJ.

Drug Metab Dispos. 2001 Jul;29(7):976-82.

PMID:
11408363
13.

Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women.

Verhoeven CH, Gloudemans RH, Groothuis GM, Rietjens IM, Vos RM.

J Steroid Biochem Mol Biol. 2000 May;73(1-2):39-48.

PMID:
10822023
14.

The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.

Gentile DM, Verhoeven CH, Shimada T, Back DJ.

J Pharmacol Exp Ther. 1998 Dec;287(3):975-82.

PMID:
9864282
15.

In vitro and in vivo metabolism of the progestagen Org 30659 in several species.

Verhoeven CH, Krebbers SF, Wagenaars GN, Booy CJ, Groothuis GM, Olinga P, Vos RM.

Drug Metab Dispos. 1998 Nov;26(11):1102-12.

PMID:
9806953
16.

In vitro and in vivo metabolism of desogestrel in several species.

Verhoeven CH, Krebbers SF, Wagenaars GN, Vos RM.

Drug Metab Dispos. 1998 Sep;26(9):927-36.

PMID:
9733673

Supplemental Content

Loading ...
Support Center